- RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- RxSight, Inc. Announces Pricing of Public Offering of Common Stock
- RxSight, Inc. Announces Proposed Public Offering of Common Stock
- RxSight, Inc. Reports First Quarter 2024 Financial Results
- RxSight, Inc. to Present at the Bank of America Healthcare Conference
- RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
- RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
- RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference
- RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
On Wednesday, Rxsight Inc (RXST:NMQ) closed at 61.78, -7.15% below its 52-week high of 66.54, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 62.89 |
---|---|
High | 64.50 |
Low | 60.59 |
Bid | 58.01 |
Offer | 63.22 |
Previous close | 62.36 |
Average volume | 527.79k |
---|---|
Shares outstanding | 38.95m |
Free float | 36.97m |
P/E (TTM) | -- |
Market cap | 2.43bn USD |
EPS (TTM) | -1.25 USD |
Data delayed at least 15 minutes, as of May 22 2024 21:00 BST.
More ▼